{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:28:58Z","timestamp":1768872538804,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,12]],"date-time":"2013-07-12T00:00:00Z","timestamp":1373587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s12253-013-9665-6","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T19:55:02Z","timestamp":1373572502000},"page":"99-106","source":"Crossref","is-referenced-by-count":16,"title":["The Prognostic Role of Claudins in Head and Neck Squamous Cell Carcinomas"],"prefix":"10.1007","volume":"20","author":[{"given":"Gy\u00f6rgyi A.","family":"Nelh\u0171bel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bor\u00f3ka","family":"K\u00e1roly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal\u00e1zs","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Lotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3zsef","family":"T\u00f3v\u00e1ri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Kenessey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,12]]},"reference":[{"key":"9665_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 5","key":"9665_CR2","doi-asserted-by":"crossref","first-page":"v61","DOI":"10.1093\/annonc\/mdg754","volume":"14","author":"M Sant","year":"2003","unstructured":"Sant M, Aareleid T, Berrino F et al (2003) EUROCARE-3: Survival of cancer patients diagnosed 1990\u201394\u2013results and commentary. Ann Oncol 14(Suppl 5):v61\u2013118","journal-title":"Ann Oncol"},{"key":"9665_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-005-5044-4","volume":"24","author":"L Dobrossy","year":"2005","unstructured":"Dobrossy L (2005) Epidemiology of head and neck cancer: Magnitude of the problem. Cancer Metastasis Rev 24:9\u201317","journal-title":"Cancer Metastasis Rev"},{"key":"9665_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00432-009-0636-y","volume":"136","author":"O Guntinas-Lichius","year":"2010","unstructured":"Guntinas-Lichius O, Wendt T, Buentzel J et al (2010) Head and neck cancer in Germany: A site-specific analysis of survival of the thuringian cancer registration database. J Cancer Res Clin Oncol 136:55\u201363","journal-title":"J Cancer Res Clin Oncol"},{"key":"9665_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1748-717X-1-11","volume":"1","author":"M Zimmermann","year":"2006","unstructured":"Zimmermann M, Zouhair A, Azria D et al (2006) The epidermal growth factor receptor (EGFR) in head and neck cancer: Its role and treatment implications. Radiat Oncol 1:11","journal-title":"Radiat Oncol"},{"key":"9665_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-3284-2-8","volume":"2","author":"M Goerner","year":"2010","unstructured":"Goerner M, Seiwert TY, Sudhoff H (2010) Molecular targeted therapies in head and neck cancer\u2013an update of recent developments. Head Neck Oncol 2:8","journal-title":"Head Neck Oncol"},{"key":"9665_CR7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.prp.2012.08.002","volume":"208","author":"CS Pereira","year":"2012","unstructured":"Pereira CS, Oliveira MV, Fraga CA et al (2012) Impact of the epithelial dysplasia grading and Ki67 proliferation index in the adjacent non-malignant mucosa on recurrence and survival in head and neck squamous cell carcinoma. Pathol Res Pract 208:651\u2013656","journal-title":"Pathol Res Pract"},{"key":"9665_CR8","first-page":"161","volume":"20","author":"A Cardesa","year":"2011","unstructured":"Cardesa A, Nadal A (2011) Carcinoma of the head and neck in the HPV era. Acta Dermatovenerol Alp Panonica Adriat 20:161\u2013173","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"9665_CR9","first-page":"199","volume":"52","author":"P Smilek","year":"2005","unstructured":"Smilek P, Dusek L, Vesely K et al (2005) Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer. Neoplasma 52:199\u2013207","journal-title":"Neoplasma"},{"key":"9665_CR10","first-page":"Doc08","volume":"11","author":"M Sadick","year":"2012","unstructured":"Sadick M, Schoenberg SO, Hoermann K et al (2012) Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg 11:Doc08","journal-title":"GMS Curr Top Otorhinolaryngol Head Neck Surg"},{"key":"9665_CR11","doi-asserted-by":"crossref","first-page":"9603","DOI":"10.1158\/0008-5472.CAN-05-2782","volume":"65","author":"PJ Morin","year":"2005","unstructured":"Morin PJ (2005) Claudin proteins in human cancer: Promising new targets for diagnosis and therapy. Cancer Res 65:9603\u20139606","journal-title":"Cancer Res"},{"key":"9665_CR12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/35067088","volume":"2","author":"S Tsukita","year":"2001","unstructured":"Tsukita S, Furuse M, Itoh M (2001) Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2:285\u2013293","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9665_CR13","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat A, Parker JS, Karginova O et al (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12:R68","journal-title":"Breast Cancer Res"},{"key":"9665_CR14","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1111\/j.1349-7006.2011.02085.x","volume":"102","author":"AM Szasz","year":"2011","unstructured":"Szasz AM, Nemeth Z, Gyorffy B et al (2011) Identification of a claudin-4 and E-cadherin score to predict prognosis in breast cancer. Cancer Sci 102:2248\u20132254","journal-title":"Cancer Sci"},{"key":"9665_CR15","first-page":"2567","volume":"9","author":"LB Rangel","year":"2003","unstructured":"Rangel LB, Agarwal R, D'Souza T et al (2003) Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 9:2567\u20132575","journal-title":"Clin Cancer Res"},{"key":"9665_CR16","first-page":"6265","volume":"63","author":"P Michl","year":"2003","unstructured":"Michl P, Barth C, Buchholz M et al (2003) Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 63:6265\u20136271","journal-title":"Cancer Res"},{"key":"9665_CR17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1309\/K144PHVDDUPDD401","volume":"121","author":"LS Nichols","year":"2004","unstructured":"Nichols LS, Ashfaq R, Iacobuzio-Donahue CA (2004) Claudin 4 protein expression in primary and metastatic pancreatic cancer: Support for use as a therapeutic target. Am J Clin Pathol 121:226\u2013230","journal-title":"Am J Clin Pathol"},{"key":"9665_CR18","first-page":"7878","volume":"61","author":"H Long","year":"2001","unstructured":"Long H, Crean CD, Lee WH et al (2001) Expression of clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 61:7878\u20137881","journal-title":"Cancer Res"},{"key":"9665_CR19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00428-007-0406-7","volume":"450","author":"K Borka","year":"2007","unstructured":"Borka K, Kaliszky P, Szabo E et al (2007) Claudin expression in pancreatic endocrine tumors as compared with ductal adenocarcinomas. Virchows Arch 450:549\u2013557","journal-title":"Virchows Arch"},{"key":"9665_CR20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.bjc.6604486","volume":"99","author":"KA Landers","year":"2008","unstructured":"Landers KA, Samaratunga H, Teng L et al (2008) Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. Br J Cancer 99:491\u2013501","journal-title":"Br J Cancer"},{"key":"9665_CR21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1464-410X.2009.08808.x","volume":"105","author":"AM Szasz","year":"2010","unstructured":"Szasz AM, Nyirady P, Majoros A et al (2010) beta-catenin expression and claudin expression pattern as prognostic factors of prostatic cancer progression. BJU Int 105:716\u2013722","journal-title":"BJU Int"},{"key":"9665_CR22","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1369\/0022155411424606","volume":"59","author":"P Torzsok","year":"2011","unstructured":"Torzsok P, Riesz P, Kenessey I et al (2011) Claudins and ki-67: Potential markers to differentiate low- and high-grade transitional cell carcinomas of the urinary bladder. J Histochem Cytochem 59:1022\u20131030","journal-title":"J Histochem Cytochem"},{"key":"9665_CR23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.humpath.2004.12.001","volume":"36","author":"G Sobel","year":"2005","unstructured":"Sobel G, Paska C, Szabo I et al (2005) Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Hum Pathol 36:162\u2013169","journal-title":"Hum Pathol"},{"key":"9665_CR24","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/j.1349-7006.2009.01239.x","volume":"100","author":"M Suzuki","year":"2009","unstructured":"Suzuki M, Kato-Nakano M, Kawamoto S et al (2009) Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers. Cancer Sci 100:1623\u20131630","journal-title":"Cancer Sci"},{"key":"9665_CR25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.abb.2012.01.009","volume":"524","author":"A Neesse","year":"2012","unstructured":"Neesse A, Griesmann H, Gress TM et al (2012) Claudin-4 as therapeutic target in cancer. Arch Biochem Biophys 524:64\u201370","journal-title":"Arch Biochem Biophys"},{"key":"9665_CR26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00428-005-0045-9","volume":"447","author":"H Gyorffy","year":"2005","unstructured":"Gyorffy H, Holczbauer A, Nagy P et al (2005) Claudin expression in Barrett's esophagus and adenocarcinoma. Virchows Arch 447:961\u2013968","journal-title":"Virchows Arch"},{"key":"9665_CR27","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1038\/sj.onc.1205351","volume":"21","author":"AE Al Moustafa","year":"2002","unstructured":"Al Moustafa AE, Alaoui-Jamali MA, Batist G et al (2002) Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 21:2634\u20132640","journal-title":"Oncogene"},{"key":"9665_CR28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1066896911424488","volume":"20","author":"A Ouban","year":"2012","unstructured":"Ouban A, Hamdan H, Hakam A et al (2012) Claudin-1 expression in squamous cell carcinomas of different organs: Comparative study of cancerous tissues and normal controls. Int J Surg Pathol 20:132\u2013138","journal-title":"Int J Surg Pathol"},{"key":"9665_CR29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.oraloncology.2011.03.020","volume":"47","author":"B Szabo","year":"2011","unstructured":"Szabo B, Nelhubel GA, Karpati A et al (2011) Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas. Oral Oncol 47:487\u2013496","journal-title":"Oral Oncol"},{"key":"9665_CR30","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1369\/0022155411418829","volume":"59","author":"E Szekely","year":"2011","unstructured":"Szekely E, Torzsok P, Riesz P et al (2011) Expression of claudins and their prognostic significance in noninvasive urothelial neoplasms of the human urinary bladder. J Histochem Cytochem 59:932\u2013941","journal-title":"J Histochem Cytochem"},{"key":"9665_CR31","first-page":"4244s","volume":"46","author":"KS McCarty Jr","year":"1986","unstructured":"McCarty KS Jr, Szabo E, Flowers JL et al (1986) Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res 46:4244s\u20134248s","journal-title":"Cancer Res"},{"key":"9665_CR32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2220\/biomedres.29.71","volume":"29","author":"K Miyamoto","year":"2008","unstructured":"Miyamoto K, Kusumi T, Sato F et al (2008) Decreased expression of claudin-1 is correlated with recurrence status in esophageal squamous cell carcinoma. Biomed Res 29:71\u201376","journal-title":"Biomed Res"},{"key":"9665_CR33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2133.2004.06029.x","volume":"151","author":"K Morita","year":"2004","unstructured":"Morita K, Tsukita S, Miyachi Y (2004) Tight junction-associated proteins (occludin, ZO-1, claudin-1, claudin-4) in squamous cell carcinoma and Bowen's disease. Br J Dermatol 151:328\u2013334","journal-title":"Br J Dermatol"},{"key":"9665_CR34","doi-asserted-by":"crossref","first-page":"R296","DOI":"10.1186\/bcr983","volume":"7","author":"AM Tokes","year":"2005","unstructured":"Tokes AM, Kulka J, Paku S et al (2005) Claudin-1, -3 and \u22124 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7:R296\u2013305","journal-title":"Breast Cancer Res"},{"key":"9665_CR35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s004390000375","volume":"107","author":"F Kramer","year":"2000","unstructured":"Kramer F, White K, Kubbies M et al (2000) Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum Genet 107:249\u2013256","journal-title":"Hum Genet"},{"key":"9665_CR36","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/modpathol.3800301","volume":"18","author":"MB Resnick","year":"2005","unstructured":"Resnick MB, Konkin T, Routhier J et al (2005) Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18:511\u2013518","journal-title":"Mod Pathol"},{"key":"9665_CR37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3892\/or.2012.2161","volume":"29","author":"K Yoshizawa","year":"2013","unstructured":"Yoshizawa K, Nozaki S, Kato A et al (2013) Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma. Oncol Rep 29:445\u2013450","journal-title":"Oncol Rep"},{"key":"9665_CR38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1471-2407-6-186","volume":"6","author":"KJ Hewitt","year":"2006","unstructured":"Hewitt KJ, Agarwal R, Morin PJ (2006) The claudin gene family: Expression in normal and neoplastic tissues. BMC Cancer 6:186","journal-title":"BMC Cancer"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9665-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-013-9665-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-013-9665-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T01:59:56Z","timestamp":1563415196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-013-9665-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["9665"],"URL":"https:\/\/doi.org\/10.1007\/s12253-013-9665-6","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,12]]}}}